跳至主要内容
临床试验/NCT02103842
NCT02103842已完成1 期

Omega-3 Fatty Acids to Combat Sarcopenia

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Mayo Clinic
入组人数
24
试验地点
1
主要终点
Change in Muscle protein synthesis

研究概览

简要总结

The purpose of this study is to determine how omega-3 fatty acids influence muscle protein metabolism and mitochondrial physiology in the context of human aging.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-35 or 65-85 years

排除标准

  • Current use of omega-3 nutritional supplements
  • Fasting plasma glucose ≥126 mg/dL
  • Active coronary artery disease
  • Participation in structured exercise (>3 times per week for 30 minutes or longer)
  • Medications known to affect muscle metabolism (e.g., beta blockers, corticosteroids, tricyclic-antidepressants, benzodiazepines, opiates, barbiturates, anticoagulants)
  • Renal failure (serum creatinine > 1.5mg/dl)
  • Chronic active liver disease (Bilirubin > 17mmol/L, AST>144IU/L, or ALT>165IU/L)
  • Anti-coagulant therapy (warfarin/heparin)
  • Use of systemic glucocorticoids
  • Chronic use of NSAIDS or aspirin
  • Pregnancy or breastfeeding
  • Alcohol consumption greater than 2 glasses/day
  • Hypothyroidism
  • Fish or shellfish allergy

研究组 & 干预措施

Omega-3 fatty acids

Experimental

Participants will take 3.9g/day of Eicosapentaenoic acid and docosahexaenoic acid for 4 months

干预措施: Omega-3 fatty acids (Drug)

结局指标

主要结局

Change in Muscle protein synthesis

时间窗: Baseline and following 4 months intervention

Skeletal muscle protein synthesis will be measured from the rate of incorporation of infused amino acids measured by mass spectrometry.

Change in Muscle mitochondrial function

时间窗: Baseline and following 4 months intervention

Mitochondrial function will be measured in isolated mitochondria by high-resolution respirometry.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ian R. Lanza

PI

Mayo Clinic

研究点 (1)

Loading locations...

相似试验

Omega-3 Fatty Acids to Combat Sarcopenia | 临床试验